Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients：a Single-center, Double- Blind, Controlled Trial

NCT06619912 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06619912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06619912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients：a Single-center, Double- Blind, Controlled Trial
Lead sponsor
Xijing Hospital
Phase
Phase 3
Overall status
Completed
Start date
March 3, 2025
Completion date
September 8, 2026
Enrollment
686 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative delirium, preoperative sleep disorder